searchGFrontNewsCommentFeaturesMARKETECONOMYENERGYHEALTHCAREITREAL ESTATESTART UPSAEROSPACE & DEFENSECHEMICALS & PLASTICSFINANCIAL SERVICESMERGERS & ACQUISITIONSPOLITICSTELECOMS, MEDIA & MARKETINGTOURISMTRANSPORT & INFRASTRUCTUREWATERFront > NewsHong Kong health department recalls Teva drugIsraeli IoT startup Neura raises $11mIsraeli IoT startup Neura raises $11m16/01/2012, 17:47Inbal OmerThe Allopurinol tablets, reportedly produced by Teva's Hungarian plant, are used to treat hyperuricaemia and gout.Hong Kong's Department of Health today ordered a recall of a batch of Allopurinol tablets made by Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA), after black substances were found on some tablets in two blisters of the product. Allopurinol is used to treat hyperuricaemia and gout.According to the Hong Kong distributor, International Medical Co. Ltd., the tablets are made by Teva Pharmaceutical Works Private Ltd Co. in Hungary.An investigation by the Department of Health found no fungal elements, and that the black substances, which adhered on the surfaces of some tablets, bear similar features as used in hydrocarbon oil. It added that the substances might be a quality issue. The Department of Health has received no reports about adverse events related to the product, but advised patients to examine the tablets before taking them.A total of 22,965 boxes had been imported into Hong Kong and were supplied to the Health Authority, local pharmacies and private doctors.Department of Health spokesman said, "In this instance, contravention of the Public Health and Municipal Services Ordinance, selling drugs not of the nature, substance or quality demanded by the purchaser, might have occurred. The maximum penalty involved is $10,000 and three months imprisonment."Published by Globes [online], Israel business news - www.globes-online.com - on January 16, 2012� Copyright of Globes Publisher Itonut (1983) Ltd. 20125 CommentsView comments in rowsUpdate by email about comments talkbackPOSTCommentsYour namePlease insert your nameContentYour commentThanks You comment was recieved and soon will be published.In posting comments, I agree to abide by the Terms of Use Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate contentPOSTThank you for posting your comment, which will be reviewed for publication.Whith ChainingWithout chainingCustomer recommendedLoading Comments...Load more comments������ ����� >>Inbal OmerFrontNewsCommentFeaturesMarketNewslettersRSSIsrael Resources�����Globes ConferencesInternationalAdvertisingAboutSupportPowered by UI & Design By Application delivery by � Globes. All rights reserved.TwitterFacebookLinkedinRSSNewsletters�����Real Estate Conference